Skip to content

Capacity addition from Tevapharm sends Marksans Pharma up 6%

Through the acquisition, the company plans to double its existing Indian capacity from 8 billion units per annum currently

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish